deucravacitinib,apremilast
bms,amgen
['psoriasis', 'bristol']
fda approves bristol-myers' sotyktu for moderate-to-severe plaque psoriasis see the rest of the story here. provides the latest financial news as it breaks. known as a leader in market intelligence, the fly's real-time, streaming 